.In general, tumor cells use MHCI molecules to present tumor antigen peptides to the cell surface, which are phagocytosed and recognized by APC cells, and then present to CD8+, CD4+ T lymphocyte via MHCI and MHCII molecules of APC cells , respectively. This evidence concerns the gene CD8A and neoplasm.